Moderna and Merck announce an investigational individualized neoantigen therapy

mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients

Fibe partners with Pristyn Care to power affordable quality healthcare across India

Affordability is key to providing accessible healthcare for Bharat.

Taros Chemicals and Welab Barcelona partner for drug Discovery and development services

The combination will support clients in getting their end-to-end discovery and development programs delivered.

Chiesi Farmaceutici completes acquisition of Amryt Pharma

Acquisition positions Chiesi to expand patient access to approved treatments and advance efforts to develop new treatments for people living with rare diseases.

Digital Health: An opportunity to increase health equity

Clinical Decision Support Systems' huge potential to help ensure that each patient can receive high-quality care; study shows a reduction in diagnostic errors from 24% to 2%

Over 60% of ambulances violates tyre safety requirements: Survey

The survey inspected ambulances operating throughout the city

Max Healthcare Institute completes acquisition of further stake in Eqova Healthcare

The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova

DG, ICMR and Director CSIR-NIScPR release special issues of Vigyan Pragati & Science Reporter magazines

Science communication brings behavioural changes

AI-backed innovations to drive Australia ultrasound systems market, says GlobalData

CiRA, Kyoto University and Astellas Phase 2 research agreement signed for iPS Cells

CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells